Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04748445 · ClinicalTrials.gov registry record
Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 9,151
- Enrollment target
NCT04748445 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 9,151 participants.
The verdict
NCT04748445 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 9,151 participants
- Enrollment target
Study Summary
The purpose of the AcRIS study is to obtain data to characterize the relationship between symptoms and voice features for (reverse transcription polymerase chain reaction (RT-PCR) confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus, or Respiratory Syncytial Virus (RSV) positive participants with acute viral respiratory illness. This data will be used as the basis to build voice and symptom algorithm(s) for detection and monitoring of these illnesses. This would benefit vaccine development across several key disease areas, including SARS-CoV-2, influenza virus and RSV. The study also models concepts of more efficient "flexible" clinical trials involving not only voice capture, but also web-based participant recruitment, enhanced participant engagement, and remote sample collection that could make future clinical studies more efficient. The clinical data obtained in this observational study could provide the documentation of the technology's performance needed to enable its deployment in future interventional studies.
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2/Influenza/RSV RT-PCR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,151 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2022-04-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04748445
The ClinicalTrials.gov registry entry for NCT04748445 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SARS-CoV-2/Influenza/RSV RT-PCR is the first listed.
NCT04748445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04748445 about?
NCT04748445 is a clinical study titled "Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.". The purpose of the AcRIS study is to obtain data to characterize the relationship between symptoms and voice features for (reverse transcription polymerase chain reaction (RT-PCR) confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus, or Respiratory Syncytial Virus ...
What is the current status of trial NCT04748445?
This trial is currently completed. The enrollment target is 9,151 participants. The study started on 2021-04-12. Estimated completion is 2022-04-22.
What interventions are being tested in trial NCT04748445?
The interventions under investigation include: SARS-CoV-2/Influenza/RSV RT-PCR (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04748445?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.